Vascular Endothelial Growth Factor: A potential diagnostic biomarker for major depression

Journal of Psychiatric Research

Volumn 59, Issue , 2014, Pages 22-27

  Clark Raymond, Anne ^a   Meresh, Edwin ^a   Hoppensteadt, Debra ^a   Fareed, Jawed ^a   Sinacore, James ^a   Halaris, Angelos ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Biomarkers; Growth factors; Major depression; Stress; VEGF

Indexed keywords

PSYCHOTROPIC AGENT; VASCULOTROPIN A; BIOLOGICAL MARKER;

ADULT; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PERCEIVED STRESS SCALE; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; BLOOD; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE;

ADULT; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84908310947     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.08.005     Document Type: Article

References (23)

1. Boldrini M., Hen R., Underwood M.D., Rosoklija G.B., Dwork A.J., Mann J.J., et al. Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression. JBiol Psychiatry 2012, 72(7):562e71.
2. Cao L., Jiao X., Zuzga D.S., Liu Y., Fong D.M., Young D., et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet 2004, 36(8):827e35.
3. Clark-Raymond A., Halaris A. VEGF and depression: a Comprehensive assessment of clinical data. JBiol Psychiatry 2013, 47(8):1080e7.
4. Cohen J., Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences 1975, Lawrence Erlbaum Associates.
5. Dome P., Telezi Z., Rihmer Z., Peter L., Dobos J., Kenessey I., et al. Circulating endothelial progenitor cells and depression: a possible link between heart and soul. Mol Psychiatry 2009, 14:523e31.
6. Duman R.S., Monteggia L.M. Aneurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116e27.
7. Elfving B., Plougmann P.H., Wegener G. Differential brain, but not serum VEGF levels in a genetic rat model of depression. Neurosci Lett 2010, 474:13e6.
8. Fornaro M., Rocchi G., Escelsior A., Contini P., Ghio M., Colicchio S., et al. VEGF plasma level variations in duloxetine-treated patients with major depression. JAffect Disord 2013, 151(2):590e5.
9. Heine V.M., Zareno J., Maslam S., Joëls M., Lucassen P.J. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci 2005, 21(5):1304e14.
10. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2006, 31:658e63.
11. Isung J., Aeinehband S., Mobarrez F., Martensson B., Nordstrom P., Asberg M., et al. Low vascular endothelial growth factor and interleukin-8 in cerebrospinal fluid of suicide attempters. Transl Psychiatry 2012, 2:e196.
12. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor stimulates neurogenesis invitro and invivo. Proc Natl Acad Sci 2002, 99(18):11946e50.
13. Kahl K.G., Bens S., Ziegler K., Rudolf S., Kordon A., Dibbelt L., et al. Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder. Psychoneuroendocrinology 2009, 34:353e7.
14. Kotan Z., Sarandöl E., Kirhan E., Özkaya G., Kirli S. Serum Brain Derived Neurotrophic Factor (BDNF), Vascular Endothelial Growth Factor (VEGF) and leptin levels in patients with the diagnosis of severe major depressive disorder with melancholic features. Ther Adv Psychopharmacol 2012, 2(2):65e74.
15. Lee B.H., Kim Y.K. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. JAffect Disord 2012, 136(1e2):181e4.
16. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989, 246(4935):1306e9.
17. McCloskey D.P., Croll S.D., Scharfman H.E. Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. JNeurosci 2005, 25(39):8889e97.
18. Storkebaum E., Lambrechts D., Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 2004, 26(9):943e54.
19. Takebyashi M., Hashimoto R., Hisaoka K., Tsuchioka M., Kunugi H. Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders. JNeural Transm 2010, 117:1119e22.
20. Tsai S.J., Hong C.J., Lious Y.J., Chen T.J., Chen M.L., Hou S.J., et al. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder. Psychiatry Res 2009, 169(2):113e7.
21. Ventriglia M., Zanardini R., Pedrini L., Placentino A., Nielson M.G., Gennarelli M., et al. VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 2009, 33:146e9.
22. Viikki M., Anttila S., Kampman O., Illi A., Huuhka M., Setälä-Soikkeli E., et al. Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression. Neurosci Lett 2010, 477:105e8.
23. Yarnold P.R., Soltysik R.C. Optimal data analysis: a guidebook with software for windows 2005, American Psychological Association, Washington, D.C.